Febrile

8 drugs in development·7 companies·1 clinical trial

Drug Pipeline by Phase

Approved(6)

Drug	Company
cefepime	Atara Biotherapeutics, Inc. (ATRA)
cefepime	Seagen Inc. (SGEN)
fulphila	Mylan II B.V. (MYL)
nypozi	GT Biopharma, Inc. (GTBP)
ROLVEDON	Assertio Holdings, Inc. (ASRT)
udenyca	Coherus Oncology, Inc. (CHRS)

Phase 3(2)

Drug	Company
peg-g-csf	TC BioPharm (Holdings) plc (TCBWF)
peg-g-csf injection (kexing biopharmaceutical co	TC BioPharm (Holdings) plc (TCBWF)

BioSniper tracks 8 drugs in development for Febrile across 7 companies.

There are 1 clinical trial targeting Febrile tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.